risk of thyroid cancer with semaglutide (Ozempic) carries FDA warnings for C-cell tumors based on rodent studies, emerging human data showing higher thyroid in early users. Over 2,900 lawsuits allege inadequate warnings for Popular diabetes drugs do not

In December 2024, NICE recommended the use of tirzepatide (Mounjaro), alongside semaglutide (Wegovy) and liraglutide (Saxenda), for the treatment of weight-related comorbidities.10 NICE recommended these drugs alongside diet and exercise, yet many patients lack structured programs offering nutritional, behavioural, and psychological support

The measurable benefits of GLP-1 therapies often outweigh the discomfort caused by side effects

This has occurred in some of my patients, where the drug has no effect, he continues

J Am Coll Cardiol 2024;83:843-64

The bottle inside is white with green coloring and has a blue cap